BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26849705)

  • 21. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 25. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
    Solovieff N; Milton JN; Hartley SW; Sherva R; Sebastiani P; Dworkis DA; Klings ES; Farrer LA; Garrett ME; Ashley-Koch A; Telen MJ; Fucharoen S; Ha SY; Li CK; Chui DH; Baldwin CT; Steinberg MH
    Blood; 2010 Mar; 115(9):1815-22. PubMed ID: 20018918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
    Bhatnagar P; Purvis S; Barron-Casella E; DeBaun MR; Casella JF; Arking DE; Keefer JR
    J Hum Genet; 2011 Apr; 56(4):316-23. PubMed ID: 21326311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
    Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
    Sebastiani P; Wang L; Nolan VG; Melista E; Ma Q; Baldwin CT; Steinberg MH
    Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
    Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
    OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia.
    Wyszynski DF; Baldwin CT; Cleves MA; Amirault Y; Nolan VG; Farrell JJ; Bisbee A; Kutlar A; Farrer LA; Steinberg MH
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):23-33. PubMed ID: 15040424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.
    Mikobi TM; Tshilobo Lukusa P; Aloni MN; Lumaka AZ; Kaba DK; Devriendt K; Matthijs G; Mbuyi Muamba JM; Race V
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
    Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
    Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
    BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
    Adekile A
    Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.
    Pule GD; Bitoungui VJN; Chemegni BC; Kengne AP; Wonkam A
    BMC Res Notes; 2017 May; 10(1):183. PubMed ID: 28499394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
    Habara AH; Shaikho EM; Steinberg MH
    Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
    Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.